Input | HPO ID | HPO term | Distance | Gene | Gene id entrez | DiseaseId | DiseaseName | DiseaseMIM | ConceptID | Source | Typical association | HGMD variants | ClinVar variants | HGNC ID | GeneMIM |
---|
HPO disease - gene - phenotype typical associations: |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | ETHE1 CL E G H | 23474 | 51188 | | | | ORPHA | 1 | | 338 | 23287 | 608451 |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | GLI3 CL E G H | 2737 | 672 | Angiofollicular ganglionic hyperplasia | | | ORPHA | 1 | | 981 | 4319 | 165240 |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | MICU1 CL E G H | 10367 | 401768 | | | | ORPHA | 1 | | 265 | 1530 | 605084 |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | MT-ATP6 CL E G H | 4508 | 644 | | | | ORPHA | 1 | | | 7414 | 516060 |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | NADK2 CL E G H | 133686 | 431361 | | | | ORPHA | 1 | | 221 | 26404 | 615787 |
HP:0012751 | HP:0012751 | Abnormal basal ganglia MRI signal intensity | 0 | SLC30A10 CL E G H | 55532 | 309854 | | | | ORPHA | 1 | | 275 | 25355 | 611146 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | ETHE1 CL E G H | 23474 | 51188 | | | | ORPHA | 1 | | 338 | 23287 | 608451 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | ETHE1 CL E G H | 23474 | 51188 | | | | ORPHA | 1 | | 338 | 23287 | 608451 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | ETHE1 CL E G H | 23474 | 51188 | | | | ORPHA | 1 | | 338 | 23287 | 608451 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | GLI3 CL E G H | 2737 | 672 | Angiofollicular ganglionic hyperplasia | | | ORPHA | 1 | | 981 | 4319 | 165240 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | GLI3 CL E G H | 2737 | 672 | Angiofollicular ganglionic hyperplasia | | | ORPHA | 1 | | 981 | 4319 | 165240 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | GLI3 CL E G H | 2737 | 672 | Angiofollicular ganglionic hyperplasia | | | ORPHA | 1 | | 981 | 4319 | 165240 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | MICU1 CL E G H | 10367 | 401768 | | | | ORPHA | 1 | | 265 | 1530 | 605084 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | MICU1 CL E G H | 10367 | 401768 | | | | ORPHA | 1 | | 265 | 1530 | 605084 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | MICU1 CL E G H | 10367 | 401768 | | | | ORPHA | 1 | | 265 | 1530 | 605084 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | MT-ATP6 CL E G H | 4508 | 644 | | | | ORPHA | 1 | | | 7414 | 516060 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | MT-ATP6 CL E G H | 4508 | 644 | | | | ORPHA | 1 | | | 7414 | 516060 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | MT-ATP6 CL E G H | 4508 | 644 | | | | ORPHA | 1 | | | 7414 | 516060 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | NADK2 CL E G H | 133686 | 431361 | | | | ORPHA | 1 | | 221 | 26404 | 615787 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | NADK2 CL E G H | 133686 | 431361 | | | | ORPHA | 1 | | 221 | 26404 | 615787 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | NADK2 CL E G H | 133686 | 431361 | | | | ORPHA | 1 | | 221 | 26404 | 615787 |
HP:0012751 | HP:0012753 | T2 hypointense basal ganglia | 1 | SLC30A10 CL E G H | 55532 | 309854 | | | | ORPHA | 1 | | 275 | 25355 | 611146 |
HP:0012751 | HP:0012752 | Focal T2 hypointense basal ganglia lesion | 1 | SLC30A10 CL E G H | 55532 | 309854 | | | | ORPHA | 1 | | 275 | 25355 | 611146 |
HP:0012751 | HP:0007183 | Focal T2 hyperintense basal ganglia lesion | 1 | SLC30A10 CL E G H | 55532 | 309854 | | | | ORPHA | 1 | | 275 | 25355 | 611146 |
HPO disease - gene - phenotype less frequent non-typical associations: |